Mitchell Sinkler & Starr Novartis Ag Transaction History

Mitchell Sinkler & Starr

  • $370 Million
  • Q4 2024

A detailed history of Mitchell Sinkler & Starr transactions in Novartis Ag stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 3,365 shares of NVS stock, worth $372,236. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,365
Previous 3,365 -0.0%
Holding current value
$372,236
Previous $387,000 15.5%
% of portfolio
0.09%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $63,678 - $72,534
600 Added 21.7%
3,365 $387,000
Q2 2024

Aug 07, 2024
BUY
$92.57 - $107.37 $255,956 - $296,878
2,765 New
2,765 $294,000
Q4 2023

Feb 12, 2024
BUY
$92.27 - $101.54 $315,563 - $347,266
3,420 Added 79.39%
7,728 $780,000
Q3 2023

Nov 01, 2023
BUY
$94.73 - $105.13 $86,204 - $95,668
910 Added 26.78%
4,308 $438,000
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $65,464 - $75,918
818 Added 31.71%
3,398 $312,000
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $194,919 - $238,701
2,580 New
2,580 $234,000
Q1 2022

Apr 19, 2022
SELL
$80.11 - $90.62 $244,736 - $276,844
-3,055 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$79.7 - $88.13 $3,985 - $4,406
50 Added 1.66%
3,055 $267,000
Q2 2021

Jul 15, 2021
SELL
$85.24 - $94.15 $37,079 - $40,955
-435 Reduced 12.65%
3,005 $274,000
Q1 2021

Apr 12, 2021
SELL
$83.5 - $98.47 $13,777 - $16,247
-165 Reduced 4.58%
3,440 $294,000
Q4 2020

Feb 09, 2021
SELL
$78.07 - $94.43 $81,973 - $99,151
-1,050 Reduced 22.56%
3,605 $340,000
Q3 2020

Oct 07, 2020
SELL
$82.14 - $91.0 $21,356 - $23,660
-260 Reduced 5.29%
4,655 $405,000
Q1 2020

Apr 07, 2020
SELL
$70.67 - $99.01 $141,340 - $198,020
-2,000 Reduced 28.92%
4,915 $405,000
Q4 2019

Jan 09, 2020
BUY
$84.35 - $95.37 $190,631 - $215,536
2,260 Added 48.55%
6,915 $655,000
Q3 2019

Nov 06, 2019
BUY
$85.54 - $94.26 $34,216 - $37,704
400 Added 9.4%
4,655 $405,000
Q3 2018

Oct 04, 2018
SELL
$66.94 - $77.43 $13,388 - $15,486
-200 Reduced 4.49%
4,255 $367,000
Q2 2018

Jul 11, 2018
SELL
$64.91 - $73.36 $14,280 - $16,139
-220 Reduced 4.71%
4,455 $337,000
Q1 2018

Apr 13, 2018
BUY
$70.39 - $84.15 $99,883 - $119,408
1,419 Added 43.58%
4,675 $378,000
Q3 2017

Oct 23, 2017
BUY
$74.14 - $77.27 $241,399 - $251,591
3,256
3,256 $280,000

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email